You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multi Epitope Tarp Peptide

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostatic Tumors, Prostate Cancer Trial run by the NCI (Autologus elutriated monocyte vaccine, Multi-epitope (ME) T-cell

Terminated
Has Results
  • Prostatic Neoplasms
  • Prostate Cancer
  • Autologus elutriated monocyte placebo vaccine
  • Multi-epitope (ME) T-cell receptor g alternate reading frame protein (TARP) vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 10, 2022

Prostate Specific Antigens, Prostate Tumors Trial run by the National Cancer Institute (NCI) (TARP peptide vaccine, TARP

Completed
Has Results
  • Prostate Specific Antigens
  • Prostate Neoplasms
  • T-cell receptor alternate reading frame protein (TARP) peptide vaccine
  • T-cell receptor alternate reading frame protein (TARP) dendritic cell vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 15, 2022

Bilateral Breast Carcinoma, Breast Inflammatory Carcinoma, Stage IB Breast Cancer AJCC v7 Trial in United States (drug, other,

Active, not recruiting
  • Bilateral Breast Carcinoma
  • +11 more
  • Scottsdale, Arizona
  • +11 more
Jan 12, 2023

Breast Ductal Carcinoma In Situ Trial in Jacksonville, Rochester (Granulocyte-Macrophage Colony-Stimulating Factor,

Recruiting
  • DCIS
  • (H2NVAC)
  • Jacksonville, Florida
  • +1 more
Jul 7, 2021

Breast Ductal Carcinoma In Situ Trial in Jacksonville, Rochester (Granulocyte-Macrophage Colony-Stimulating Factor,

Recruiting
  • Breast Ductal Carcinoma In Situ
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • +2 more
  • Jacksonville, Florida
  • +1 more
Dec 10, 2021

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7 Trial in United States

Recruiting
  • Breast Adenocarcinoma
  • +7 more
  • Multi-epitope HER2 Peptide Vaccine TPIV100
  • +5 more
  • Scottsdale, Arizona
  • +26 more
Aug 17, 2022

Melanoma (Skin) Trial in Philadelphia, Houston, Charlottesville (incomplete Freund's adjuvant, melanoma helper peptide vaccine,

Completed
Has Results
  • Melanoma (Skin)
  • incomplete Freund's adjuvant
  • +4 more
  • Philadelphia, Pennsylvania
  • +2 more
Mar 25, 2021

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Germany (Cyclophosphamide (Non-IMP,

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • Cyclophosphamide (Non-IMP, Lymphodepletion)
  • +3 more
  • Ulm, Baden-Württemberg, Germany
  • +4 more
Jul 24, 2023

Melanoma (Skin) Trial in Charlottesville (biological, drug, procedure)

Completed
  • Melanoma (Skin)
  • incomplete Freund's adjuvant
  • +6 more
  • Charlottesville, Virginia
    University of Virginia Cancer Center
Mar 26, 2020

Tumors Trial in Tijuana (Neoantigen Peptides)

Recruiting
  • Neoplasms
  • Neoantigen Peptides
  • Tijuana, Baja California, Mexico
    Instituto de Medicina Regenerativa
Jul 22, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +20 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 7, 2022

Prostate Cancer Trial in New York (PGV-001, Poly-ICLC, CDX-301)

Recruiting
  • Prostate Cancer
  • PGV-001
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai (ISMMS)
Aug 10, 2021

Leukemia, Chronic Lymphatic Trial in Stuttgart, Tuebingen (Peptide Vaccine, Imiquimod)

Completed
  • Leukemia, Chronic Lymphatic
  • Stuttgart, Baden-Wuerttemberg, Germany
  • +4 more
Nov 24, 2022

Ovarian Cancer Trial in United States (TPIV200, Durvalumab)

Completed
Has Results
  • Ovarian Cancer
  • TPIV200
  • Durvalumab
  • Basking Ridge, New Jersey
  • +4 more
Nov 1, 2021

Nasopharyngeal Carcinoma by AJCC V8 Stage Trial in China (Nimotuzumab, Gemcitabine, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma by AJCC V8 Stage
  • Baise, Guangxi, China
  • +8 more
Jan 29, 2023

HIV-Infected Individuals Trial in Baltimore (DD HST-NEETs)

Recruiting
  • HIV-Infected Individuals
  • DD HST-NEETs
  • Baltimore, Maryland
    Johns Hopkins University(Jhu)
Mar 2, 2022

Healthy Trial in Buffalo (Tarp Assisted Cooling, passive cooling)

Completed
  • Healthy
  • Tarp Assisted Cooling
  • passive cooling
  • Buffalo, New York
    Center for Research and Exercise in Special Environments
Feb 14, 2022

Peanut Allergy Trial in United States (DBV712 250 mcg)

Enrolling by invitation
  • Peanut Allergy
  • DBV712 250 mcg
  • Little Rock, Arkansas
  • +7 more
Mar 3, 2022

Melanoma (Skin) Trial in Tampa (MART-1, NY-ESO-1, gp100:209-217(210M))

Completed
  • Melanoma (Skin)
  • MART-1
  • +5 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 17, 2023

Rheumatoid Arthritis Trial in Worldwide (Abatacept, Adalimumab, Methotrexate)

Recruiting
  • Rheumatoid Arthritis
  • Fullerton, California
  • +76 more
Aug 12, 2022

HIV Trial in South Africa, United States (sD-NP-GT8 DNA, IL-12 DNA, Trimer 4571)

Not yet recruiting
  • HIV Infections
  • sD-NP-GT8 DNA
  • +4 more
  • Birmingham, Alabama
  • +5 more
Mar 10, 2023

Metastatic Triple-Negative Breast Carcinoma Trial (PVX-410)

Not yet recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • (no location specified)
Apr 18, 2022

Diabetes, Type 1 Trial (Abrocitinib 200 MG Oral Tablet, Ritlecitinib, Placebo)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Abrocitinib 200 MG Oral Tablet
  • +2 more
  • (no location specified)
Feb 21, 2023

Type 2 Diabetes, Multiple Dose Insulin Therapy Trial (Personalized treatment)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Multiple Dose Insulin Therapy
  • Personalized treatment
  • (no location specified)
Nov 18, 2023